Tibsovo

*
Pharmacy Only: Prescription
  • Company:

    Servier Laboratories Ireland Ltd
  • Status:

    Updated
  • Legal Category:

    Product subject to restricted prescription (C)
  • Active Ingredient(s):

    This medicinal product is subject to additional monitoring.

    *Additional information is available within the SPC or upon request to the company

qrcode image

Scan the QR code or enter an email to access and share this medicine:

Updated on 10 March 2026

File name

Tibsovo 250mg Pil - Cl.pdf

Reasons for updating

  • Change to section 2 - interactions with other medicines, food or drink
  • Change to section 6 - date of revision

Updated on 03 March 2026

File name

Tibsovo 250mg SmPC-CL.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 4.4 - Special warnings and precautions for use
  • Change to section 4.5 - Interaction with other medicinal products and other forms of interaction
  • Change to section 5.1 - Pharmacodynamic properties
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to restricted prescription (C)

Free text change information supplied by the pharmaceutical company

  • Change in ATC code from L01XM62 to L01XM02;
  • Change in the Summary of product Characteristics intended to improve the comprehension of the posology by HCPs 4.2
  • Update of section 4.5 of the SmPC to include atazanavir as an example of a drug–drug interaction with Ivosidenib
  • update SmPC section 5.1 
  •  Section 4.4: correction of “See section 4.5” to “See section 4.2”
  • Section 5.1: Correction of a typo in the date in notes from Table 5 
  • Section 10: correction of website address


Updated on 17 January 2024

File name

Tibsovo PIL.pdf

Reasons for updating

  • Improved presentation of PIL

Updated on 17 January 2024

File name

Tibsovo SmPC.pdf

Reasons for updating

  • Change to section 6.3 - Shelf life
  • Change to section 10 - Date of revision of the text

Legal category:Product subject to restricted prescription (C)

Updated on 09 June 2023

File name

Tibsovo SmPC.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration

Legal category:Product subject to restricted prescription (C)

EDM Updated on 11 May 2023

File name

Tibsovo PAC.pdf

Reasons for updating

  • Add New Doc

Updated on 11 May 2023

File name

Tibsovo SmPC.pdf

Reasons for updating

  • New SPC for new product

Legal category:Product subject to restricted prescription (C)

Updated on 11 May 2023

File name

Tibsovo PIL.pdf

Reasons for updating

  • New PIL for new product

Servier Laboratories Ireland Ltd

Servier Laboratories Ireland Ltd